Sana Biotechnology
SANA
155 hedge funds and large institutions have $398M invested in Sana Biotechnology in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 47 reducing their positions, and 30 closing their positions.
83% more call options, than puts
Call options by funds: $1.74M | Put options by funds: $952K
58% more capital invested
Capital invested by funds: $252M → $398M (+$146M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
6% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 47
1.83% less ownership
Funds ownership: 66.34% → 64.52% (-1.8%)
4% less funds holding
Funds holding: 161 → 155 (-6)
17% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
+$7.75M |
| 2 |
Corient Private Wealth
Miami,
Florida
|
+$1.7M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.62M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.45M |
| 5 |
Morgan Stanley
New York
|
+$1.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$9.15M |
| 2 |
State Street
Boston,
Massachusetts
|
-$5.43M |
| 3 |
BlackRock
New York
|
-$1.24M |
| 4 |
IHAM
Integral Health Asset Management
New York
|
-$1.03M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$923K |
SANA Hedge Fund Activity: Q2 2025 in Review
155 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Sana Biotechnology (SANA) for Q2 2025, worth a combined $398M — up 58% from $252M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of SANA and 25 opened new positions — a net loss of 5 holders — while 47 trimmed existing stakes and 50 added.
The largest buyer was Marex Group, adding an estimated $7.75M. The largest seller was Capital World Investors, exiting entirely with an estimated $9.15M sold.
- 155 institutional investors held Sana Biotechnology (SANA) as of Q2 2025, down from 161 in Q1 2025.
- Funds reported $398M of Sana Biotechnology stock for Q2 2025, up 58% quarter-over-quarter.
- 25 funds opened new Sana Biotechnology positions in Q2 2025 and 30 closed out, a net change of -5 holders.
- The largest Sana Biotechnology buyer in Q2 2025 was Marex Group, an estimated $7.75M added.
- The largest Sana Biotechnology seller in Q2 2025 was Capital World Investors, an estimated $9.15M sold.
Based on aggregated 13F filings for Q2 2025.